In a new pharmaphorum podcast, web editor Nicole Raleigh is joined by Piet van der Graaf, Senior VP at Certara – a company ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

Medical charity Wellcome has provided £2 million ($2.6 million) in additional funding to the UK's MHRA medicines regulator and reimbursement authority NICE, to help advance the development of digital ...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights, following a ...

Donor plasma samples contain information that could lead to massive advances in disease prevention. pharmaphorum grabbed a ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...

Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120 as a treatment for anxiety.